Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.
about
Biobanking and translation of human genetics and genomics for infectious diseasesAberrant DNA methylation in cervical carcinogenesisCancer diagnostic classifiers based on quantitative DNA methylationHuman papillomavirus and cervical cancer: biomarkers for improved prevention effortsEpigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population.Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasmsDevelopment of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrapeA DNA methylation classifier of cervical precancer based on human papillomavirus and human genesPAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPVQuantitative survey of multiple CpGs from 5 genes identifies CpG methylation panel discriminating between high- and low-grade cervical intraepithelial neoplasiaA promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive womenLower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasmTriage of Atypical Glandular Cell by SOX1 and POU4F3 Methylation: A Taiwanese Gynecologic Oncology Group (TGOG) StudyDNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive womenTriage of high-risk human papillomavirus-positive women by methylated POU4F3.A Pyrosequencing Assay for the Quantitative Methylation Analysis of GALR1 in Endometrial Samples: Preliminary Results.Longitudinal assessment of DNA methylation changes during HPVE6E7-induced immortalization of primary keratinocytes.Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia.Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.JAM3 methylation status as a biomarker for diagnosis of preneoplastic and neoplastic lesions of the cervixNovel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancerHPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology.Decreased MALL expression negatively impacts colorectal cancer patient survivalThe role of the retinoblastoma protein-interacting zinc finger gene 1 tumor suppressor gene in human esophageal squamous cell carcinoma cellsCredentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.Molecular biomarkers in cervical cancer diagnosis: a critical appraisal.SLC25A26 overexpression impairs cell function via mtDNA hypermethylation and rewiring of methyl metabolism.Triage of high-risk HPV positive women in cervical cancer screening.Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.MicroRNAs in HPV associated cancers: small players with big consequences.Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer PatientsPerformance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer.Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women.p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population.Claudin-1 as a Biomarker of Cervical Cytology and Histology.Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
P2860
Q24658617-FA99A5DE-B20F-40D1-84F1-649CA3816AC6Q26830289-3366EE5F-CC52-402F-BE82-B55866C974C1Q27012960-9CCD4AFB-3565-41CE-8D73-A266E468491CQ27023127-C9A23A2B-B51F-4531-B1F1-F3B058DEEC80Q33887581-6EBDB861-35AC-45E0-977F-5F21249D625FQ34345597-2BF36CB3-BF48-4FFB-A3CA-ABD0975196D1Q34486779-8801F4BB-C015-4FC8-8810-1A6D3BCE54BDQ34531028-4F9828FF-DB4F-46CC-AF39-8E577447BC48Q35000542-638E715C-4E6F-4E91-905B-F90211CD27ADQ35032304-0B31AA12-EABB-46BC-9C9E-46DDA2576AABQ35101902-D87AD254-0A29-46F3-8FD5-78D3F6BD0FD5Q35125113-5B73E953-C725-473A-B279-2EF81C6EFAE0Q35530288-7AFC7360-E61C-4A58-B917-40B16170C358Q35634408-AE2F2098-4614-42AA-B52E-2C25887FEE7EQ35658404-B31CC26F-0C67-4811-9C5E-88C500120E9CQ35678378-15289C6C-8BE9-49D4-AD6A-6FC704D9EA74Q35986654-0F022317-E2F5-4898-A399-C6B28BF30B0AQ36173002-B1C849B1-298F-422C-BEE7-BDA4CA7EB49DQ36212820-6100A5B5-0CCA-48AE-BF96-F9BE779FA5E1Q36402765-B5ADD2F6-0374-45BF-B5B6-4A1CEC426554Q36668105-FF9AD0B6-6A7D-42CD-8233-7ECEF4C4AB88Q36688981-33A8D822-C008-4B6E-A0E9-639AA8EEF9A0Q36906172-D00373C9-D498-47A1-A5E8-2FD07E7066F7Q37001814-5CF72351-B128-47D0-A99B-235A2B0690CAQ37225710-E01478FF-65CE-4248-BA91-14BCA0DE20D4Q37325156-2124E52B-4B29-496F-AF3F-7BA111BEBE99Q37706679-FD33E2A8-C042-4EEE-BB42-2D9E89B29C51Q38115352-1F2A52CC-41E3-4B93-A98E-9B1E6DC34032Q38719674-8965CFCE-C3A2-4FC2-BE54-97286AC54C3AQ38824019-E2E64625-30EB-4BAD-900D-C740AC8D0072Q39151945-59BD9981-1D2D-4AFC-B541-44B50D12496EQ39361627-67831390-EC47-4CFD-9133-8491E1B4738FQ40202976-5CA8B2AE-2F60-4382-9E1E-412833765849Q40316397-B37193EA-1A83-4A90-A926-FEBACDD80984Q40440825-651F290F-A283-4DE2-88A8-87B85ECAC12DQ40525853-2DA00805-02DC-4ED5-A59F-A5F90DEA0DA7Q40651861-22BE5B8A-D049-49AC-A497-912110154E61Q40767169-BB235408-1C82-4122-B417-D567B1CF3166Q40954466-095A4AFE-2EDC-4D24-B2C6-A6D438434A43Q41027688-3A0D71DA-4B66-4E3A-9BB4-50AB2BAAD330
P2860
Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Combined CADM1 and MAL promote ...... high-risk HPV-positive women.
@en
Combined CADM1 and MAL promoter methylation analysis to detect
@nl
type
label
Combined CADM1 and MAL promote ...... high-risk HPV-positive women.
@en
Combined CADM1 and MAL promoter methylation analysis to detect
@nl
prefLabel
Combined CADM1 and MAL promote ...... high-risk HPV-positive women.
@en
Combined CADM1 and MAL promoter methylation analysis to detect
@nl
P2093
P2860
P50
P356
P1476
Combined CADM1 and MAL promote ...... n high-risk HPV-positive women
@en
P2093
Albertus T Hesselink
Chris J L M Meijer
Daniëlle A M Heideman
Folkert J van Kemenade
Jacqueline A Louwers
Johannes Berkhof
Nathalie Fransen Daalmeijer
Peter J F Snijders
René H M Verheijen
Renée M Overmeer
P2860
P304
P356
10.1002/IJC.25890
P577
2011-03-11T00:00:00Z